Paper29463546
Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.
de Paula TP and 10 others. Antimicrob Agents Chemother, 2018. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice. Papers, record 29463546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29463546
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Atorvastatin | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Imipenem | Major topic |
| Klebsiella Infections | Major topic |
| Klebsiella pneumoniae | Major topic |
| Pneumonia, Bacterial | Major topic |
| Animals | |
| Bacterial Load | |
| Chemokines | |
| Community-Acquired Infections | |
| Drug Resistance, Multiple, Bacterial | |
| Drug Therapy, Combination | |
| Female | |
| Inflammation | |
| Macrophages | |
| Mice | |
| Mice, Inbred C57BL | |
| Neutrophils | |
| Phagocytosis |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20937845 | CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. | J Immunol | 2010 | https://conductscience.org/library/papers/20937845 | PubMed |
| 2 | 15023865 | Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/15023865 | PubMed |
| 3 | 12860913 | Statins promote potent systemic antioxidant effects through specific inflammatory pathways. | Circulation | 2003 | https://conductscience.org/library/papers/12860913 | PubMed |
| 4 | 16877692 | Potential therapeutic role for statins in respiratory disease. | Thorax | 2006 | https://conductscience.org/library/papers/16877692 | PubMed |
| 5 | 19608720 | Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. | Am J Respir Crit Care Med | 2009 | https://conductscience.org/library/papers/19608720 | PubMed |
| 6 | 21977167 | Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients. | Maedica (Bucur) | 2010 | https://conductscience.org/library/papers/21977167 | PubMed |
| 7 | 20659133 | Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. | Clin Exp Pharmacol Physiol | 2010 | https://conductscience.org/library/papers/20659133 | PubMed |
| 8 | 10448890 | Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats. | Eur J Pharmacol | 1999 | https://conductscience.org/library/papers/10448890 | PubMed |
| 9 | 16269144 | Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages. | Exp Mol Pathol | 2006 | https://conductscience.org/library/papers/16269144 | PubMed |
| 10 | 11699592 | Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines. | J Med Microbiol | 2001 | https://conductscience.org/library/papers/11699592 | PubMed |
| 11 | 27040132 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27040132 | PubMed |
| 12 | 15998696 | Statin treatment after onset of sepsis in a murine model improves survival. | Circulation | 2005 | https://conductscience.org/library/papers/15998696 | PubMed |
| 13 | 22379035 | Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. | J Immunol | 2012 | https://conductscience.org/library/papers/22379035 | PubMed |
| 14 | 22564676 | Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. | Ann Clin Microbiol Antimicrob | 2012 | https://conductscience.org/library/papers/22564676 | PubMed |
| 15 | 22054338 | Risk of pneumonia in patients taking statins: population-based nested case-control study. | Br J Gen Pract | 2011 | https://conductscience.org/library/papers/22054338 | PubMed |
| 16 | 25869507 | Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis. | Vascul Pharmacol | 2015 | https://conductscience.org/library/papers/25869507 | PubMed |
| 17 | 22210917 | Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. | J Immunol | 2012 | https://conductscience.org/library/papers/22210917 | PubMed |
| 18 | 16341063 | Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/16341063 | PubMed |
| 19 | 11943658 | Killing of Klebsiella pneumoniae by human alveolar macrophages. | Am J Physiol Lung Cell Mol Physiol | 2002 | https://conductscience.org/library/papers/11943658 | PubMed |
| 20 | 9237044 | Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin. | Endothelium | 1997 | https://conductscience.org/library/papers/9237044 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42800805 | Gut microbiota-derived acetate mitigates Escherichia fergusonii-induced gut dysbiosis exacerbating Klebsiella pneumoniae pulmonary infection in mice. | Commun Biol | 2026 | https://conductscience.org/library/papers/42800805 | PubMed |
| 41165829 | A novel anti-acute lung injury mechanism of astilbin: inhibition of epithelial cells ferroptosis by targeting NRF2 activation via binding Val608 site of NRF2. | Inflamm Res | 2025 | https://conductscience.org/library/papers/41165829 | PubMed |
| 41011446 | New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections. | Microorganisms | 2025 | https://conductscience.org/library/papers/41011446 | PubMed |
| 37760764 | Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37760764 | PubMed |
| 36695576 | Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity. | Infect Immun | 2023 | https://conductscience.org/library/papers/36695576 | PubMed |
| 36287114 | Autophagy, cell death, and cytokines in K. pneumoniae infection: therapeutic perspectives. | Emerg Microbes Infect | 2023 | https://conductscience.org/library/papers/36287114 | PubMed |
| 36160241 | Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36160241 | PubMed |
| 33906301 | Antiangiogenic and Proapoptotic Activities of Atorvastatin and Ganoderma lucidum in Tumor Mouse Model via VEGF and Caspase-3 Pathways. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/33906301 | PubMed |
| 33046059 | Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice. | BMC Pulm Med | 2020 | https://conductscience.org/library/papers/33046059 | PubMed |
| 32380052 | Granulocyte-targeted therapies for airway diseases. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32380052 | PubMed |
| 31315875 | Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. | BMJ Open | 2019 | https://conductscience.org/library/papers/31315875 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29463546
GET https://conductscience.org/api/papers/v1/29463546/references?page=2